Date updated:01-26-2007
No description available

-
DVN
Devon Energy Cp ( - $67.58
- -1.47%
- $68.26
No Analysis added

-
STJ
St. Jude Medical - $36.96
- -0.35%
- $37.01
No Analysis added

-
TRIB
Trinity Biotech P - $4.30
- 0.00%
- $N/A
No Analysis added

-
OSUR
Orasure Technolog - $3.94
- +0.51%
- $3.90
No Analysis added

-
BQI
Oilsands Quest In - $1.23
- -3.91%
- $1.25
No Analysis added

-
PRU
Prudential Fincl - $50.24
- +1.03%
- $49.94
No Analysis added

-
SLB
Schlumberger Ltd - $63.99
- -1.02%
- $64.35
No Analysis added

-
JQC
Nuveen Ms I&g Fd - $7.37
- +0.82%
- $7.32
No Analysis added
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Charlie Munger
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
Posted on Dec. 2, 2009 Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional...
By Jonas Elmerraji Posted on Dec. 2, 2009 It’s been a tough year for regional banks. While investors mulled over the fate of the big three banks -- Citigroup (C), Ban...
By Jonas Elmerraji Posted on Dec. 1, 2009 After an earnings season that has brought a significant stream of dividend-increasers, stocks are taking a step back, with jus...
By Roberto Pedone Posted on Dec. 1, 2009 Bullish and Bearish: Each week, Barron’s publishes bullish and bearish stories on a variety of stocks. We present summaries o...
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some of the biggest stocks that made the 52-week high list on Dec. 2, 2009. more
Here are some of the largest % gainers from Dec. 2, 2009. more
TheStreet Ratings provides exclusive stock, ETF and mutual fund ratings and commentary based on award-winning, proprietary tools. Its "safety first" approach to investing a... more











Comments not available